Tobacco juggernaut Philip Morris International reported a strong quarter, including a 5.8% growth in revenue, in large part ...

The CEO of Philip Morris International's U.S. business argued that nicotine is "misunderstood" and contains "cognitive ...

Oral nicotine product Zyn has skyrocketed in sales and popularity in recent years. This growth has brought controversy and ...

Philip Morris International raises profit forecasts, driven by the robust performance of ZYN and demand for smoking ...

The company still has big potential growth opportunities ahead.

Philip Morris's Zyn sees explosive growth with soaring demand and a new factory in Colorado. See why I rate PM stock a strong ...

Philip Morris's stock surged over 41.50% in 2025, driven by the success of its innovative nicotine pouch product, Zyn, which ...

A new study found that nicotine pouch use nearly doubled in one year among teens. Some use them in combination with vapes.

Shares of Philip Morris International set an all-time high Wednesday after the tobacco giant topped first-quarter estimates ...

Tobacco juggernaut Philip Morris International reported a strong quarter, including a 5.8% growth in revenue, in large part because of the soaring popularity of Zyn. U.S. shipments of the nicotine ...

ZYN's surging popularity quickly rebounded ... to impact the timing of an application to sell a later version of the IQOS device. Philip Morris expects adjusted annual profit in the range of ...